About | Free Trial

Last Update


This profile was last updated on . .

Is this you? Claim your profile.

Wrong Kate Bingham?

Dr. Kate Bingham

Managing Partner

SV Life Sciences

Direct Phone: +44 **********       

Email: k***@***.com

SV Life Sciences

1700 Owens St Ste 184

San Francisco, California 94158

United States

Company Description

SV Life Sciences is a venture capital fund providing financing to businesses at all stages of development across the human life sciences sector, including biotechnology, pharmaceuticals, medical devices and instruments, and healthcare information technolo... more

Find other employees at this company (66)

Background Information

Employment History

Head of Technology Media and Telecoms Department

Denton Wilde Sapte LLP


SNR Denton

Position, Business Development

Vertex Pharmaceuticals Incorporated


Advisory Board Member

Board Member
Pulmocide LTD

Investment Committee As Well As the Investment Committees

Board Member
Autifony Therapeutics Limited

Board Member
Bicycle Therapeutics Limited

MedCity Limited

Council Member
British Venture Capital Association

Board Member
RespiVert LTD

Board Member
Affibody AB

Board Member
Trine Pharmaceuticals , Inc.

Member, S Supervisory Board
Ingenium Pharmaceuticals GmbH

Board Member
Dynogen Pharmaceuticals , Inc.

Board Member
PowderMed Ltd

Board Member

Board Member

Board Member

Board Member

Board Member

Board Member


Oxford University


Harvard Business School

Masters degree
Oxford University

first class Masters degree
University Oxford

first class degree
Oxford University

Web References (170 Total References)

Our people - Medcity

www.medcityhq.com [cached]

Kate Bingham Managing Partner, SV Life Sciences

Kate Bingham is one of the UK's leading life sciences venture capitalists. She currently serves or has served on the boards of companies in the UK, US, Ireland, Sweden and Germany. She has been responsible for past investments in Alantos, Auxilium, ESBATech, EUSA, Hexagen, Kinetix, KuDOS, Leukosite, Mednova, Micromet, PowderMed, RespiVert and current investments including Autifony, Bicycle, Convergence, Pulmocide, Oncoethix,TopiVert and VHSquared

Kate Bingham, Managing ...

www.biotrinity.com [cached]

Kate Bingham, Managing Partner, SV Life Sciences

Kate Bingham, Managing ...

bvca.co.uk [cached]

Kate Bingham, Managing Partner, SV Life Sciences

Before joining SVLS, Hamish ...

www.topivert.com [cached]

Before joining SVLS, Hamish was CEO of Cambridge Antibody Technology (CAT).

Kate Bingham (Observer)
Kate is a Managing Partner at SV Life Sciences Advisers, LLC (SVLS). She has been responsible for many successful venture capital investments in biotechnology companies, since joining the firm in 1991. Kate currently serves as a Director of Autifony Therapeutics, Bicycle Therapeutics, Calchan and Convergence Pharmaceuticals. Previously, she worked in business development at Vertex Pharmaceuticals and at Monitor Company. She graduated from Harvard Business School with an MBA, where she was a Baker Scholar, and also holds a first class Masters degree in Biochemistry from the University Oxford.

Biologics - FiercePharma Manufacturing | Page 8

www.FiercePharmaManufacturing.com [cached]

Kate Bingham, managing partner at SV Life Sciences, says that biologics are "hot" right now for investors. Speaking at a European conference, Bingham said that

Similar Profiles

Other People with this Name

Other people with the name Bingham

Laura Bingham
Campbell-Bell Communications

Roy Bingham
BDS Analytics

Tracy Bingham
HomeServices of America , Inc. company

Peter Bingham
Julie's Bicycle Ltd

Curtis Bingham
Chief Customer Officer Council

Browse ZoomInfo's Business Contact Directory by City

Browse ZoomInfo's
Business People Directory

Browse ZoomInfo's
Advanced Company Directory